URMC Research Network

Find People
Keyword
Last Name
 
More Search Options

Aram Hezel

Concepts (204)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of pubs Most recent pub Pubs by all authors Concept score Why?
Pancreatic Neoplasms
13
2006
85
3.820
Why?
Biliary Tract Neoplasms
3
2008
6
2.070
Why?
Carcinoma, Pancreatic Ductal
7
2006
13
1.850
Why?
Cholangiocarcinoma
4
2008
13
1.790
Why?
Liver Neoplasms
4
2009
149
1.760
Why?
Protein-Serine-Threonine Kinases
6
2002
243
1.510
Why?
Pancreas
3
2006
125
1.200
Why?
Disease Models, Animal
7
2006
908
1.170
Why?
Gallbladder Neoplasms
3
2010
8
1.120
Why?
Phosphatidylinositol 3-Kinases
5
2007
133
1.060
Why?
Proto-Oncogene Proteins p21(ras)
3
2011
16
1.050
Why?
Tumor Suppressor Protein p53
5
2001
134
1.010
Why?
Carcinoma, Hepatocellular
2
2009
68
0.920
Why?
Signal Transduction
9
2005
1465
0.840
Why?
Integrins
1
2012
45
0.810
Why?
Antigens, Neoplasm
1
2012
105
0.760
Why?
Molecular Targeted Therapy
1
2011
20
0.730
Why?
Radiosurgery
1
2011
73
0.730
Why?
Transforming Growth Factor beta
2
2006
362
0.700
Why?
Colorectal Neoplasms
2
2007
138
0.680
Why?
Carcinoma
1
2011
188
0.650
Why?
Cellular Structures
1
2008
3
0.650
Why?
Genomic Instability
2
2005
20
0.640
Why?
Liver Transplantation
1
2011
246
0.640
Why?
Proto-Oncogene Proteins c-pim-1
1
2008
1
0.640
Why?
Telomere
2
2005
27
0.630
Why?
Genes, ras
6
2001
34
0.620
Why?
Neoplastic Syndromes, Hereditary
1
2008
1
0.610
Why?
Cystadenoma, Serous
1
2008
2
0.610
Why?
Disease Progression
7
2006
496
0.610
Why?
Proto-Oncogene Proteins
4
2007
261
0.600
Why?
Adenocarcinoma
5
2006
431
0.560
Why?
Animals
22
1999
15647
0.560
Why?
Mice
17
1999
5900
0.560
Why?
ras Proteins
3
2010
34
0.550
Why?
Tumor Markers, Biological
1
2008
221
0.530
Why?
Genes, Tumor Suppressor
4
2002
49
0.480
Why?
Humans
23
2005
35000
0.480
Why?
Antineoplastic Agents
4
2007
598
0.470
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2008
409
0.460
Why?
Mutation
5
2008
1183
0.440
Why?
Protein Kinases
3
2007
110
0.420
Why?
Neoplasms
1
2008
701
0.400
Why?
Bile Ducts, Intrahepatic
2
2011
8
0.390
Why?
Bile Duct Neoplasms
2
2011
14
0.390
Why?
TOR Serine-Threonine Kinases
3
2007
29
0.380
Why?
Deoxycytidine
3
2008
26
0.370
Why?
Indoles
2
2009
93
0.340
Why?
Lung Neoplasms
3
2006
422
0.340
Why?
Aging
1
2005
692
0.320
Why?
Cell Polarity
2
2008
23
0.310
Why?
Peutz-Jeghers Syndrome
2
2002
3
0.270
Why?
Cell Transformation, Neoplastic
3
2002
134
0.270
Why?
Treatment Outcome
4
2007
2487
0.250
Why?
Mice, Mutant Strains
5
1999
119
0.240
Why?
Cyclin-Dependent Kinase Inhibitor p16
4
2001
15
0.240
Why?
Middle Aged
7
2008
9461
0.240
Why?
Gene Deletion
4
2002
191
0.230
Why?
Aged
5
2008
6986
0.220
Why?
Isocitrate Dehydrogenase
1
2011
23
0.200
Why?
Waiting Lists
1
2011
12
0.200
Why?
Tumor Burden
1
2011
22
0.200
Why?
Genetic Engineering
1
2012
21
0.200
Why?
Dose Fractionation
1
2011
57
0.190
Why?
Necrosis
1
2011
99
0.190
Why?
Tumor Suppressor Protein p14ARF
3
2001
6
0.190
Why?
beta Karyopherins
1
2011
14
0.190
Why?
PTEN Phosphohydrolase
1
2011
14
0.190
Why?
Organ Size
1
2011
189
0.190
Why?
Validation Studies as Topic
1
2011
3
0.190
Why?
Tubulin
1
2011
56
0.190
Why?
Mice, Transgenic
3
2008
735
0.190
Why?
Immunohistochemistry
2
2006
1024
0.190
Why?
Female
8
2007
19061
0.180
Why?
Cisplatin
1
2011
93
0.180
Why?
DNA Mutational Analysis
1
2011
185
0.180
Why?
Male
7
2008
18870
0.170
Why?
Proto-Oncogene Proteins c-akt
2
2007
114
0.170
Why?
Drug Therapy, Combination
1
2011
375
0.170
Why?
NF-kappa B
2
2007
405
0.170
Why?
Aged, 80 and over
3
2009
2423
0.170
Why?
MAP Kinase Signaling System
1
2010
86
0.170
Why?
Mice, Knockout
3
2002
857
0.160
Why?
Pyrroles
1
2009
19
0.160
Why?
Amyloid Precursor Protein Secretases
1
2009
11
0.160
Why?
p21-Activated Kinases
1
2008
3
0.160
Why?
Pancreatic Ducts
1
2008
4
0.160
Why?
rho GTP-Binding Proteins
1
2008
20
0.160
Why?
Sirolimus
1
2008
31
0.160
Why?
Liver
2
1999
870
0.160
Why?
Receptors, Notch
1
2009
50
0.150
Why?
Metaplasia
1
2008
16
0.150
Why?
Neoplasms, Squamous Cell
1
2008
9
0.150
Why?
Tight Junctions
1
2008
17
0.150
Why?
Fluorouracil
1
2008
77
0.150
Why?
Islets of Langerhans
1
2008
86
0.150
Why?
Carcinogens
1
2008
61
0.150
Why?
Cohort Studies
1
2011
912
0.150
Why?
Antibodies, Monoclonal
1
2011
725
0.150
Why?
Cytokines
1
2011
555
0.140
Why?
Cytoskeleton
1
2008
73
0.140
Why?
Proto-Oncogene Proteins c-met
1
2007
15
0.140
Why?
Receptors, Growth Factor
1
2007
26
0.140
Why?
Energy Metabolism
1
2008
132
0.140
Why?
Magnesium Compounds
1
2007
5
0.140
Why?
Prednisolone
1
2007
24
0.140
Why?
src-Family Kinases
1
2007
61
0.140
Why?
Smad4 Protein
1
2006
15
0.140
Why?
Calcium Oxalate
1
2007
32
0.140
Why?
Protein Processing, Post-Translational
1
2008
132
0.140
Why?
Cats
1
2007
204
0.140
Why?
Models, Biological
2
2007
982
0.140
Why?
Receptor, Epidermal Growth Factor
1
2007
90
0.130
Why?
Adult
5
2008
10906
0.130
Why?
Protein Kinase Inhibitors
1
2007
91
0.130
Why?
Biological Markers
1
2009
532
0.130
Why?
Phosphates
1
2007
145
0.130
Why?
Enzyme Activation
1
2008
511
0.130
Why?
Genes, p53
1
2006
50
0.130
Why?
Retinoblastoma Protein
2
2001
35
0.130
Why?
Cell Line, Tumor
4
2006
543
0.130
Why?
Anti-Inflammatory Agents
1
2007
109
0.130
Why?
Randomized Controlled Trials as Topic
1
2008
400
0.130
Why?
Epithelial Cells
1
2008
324
0.130
Why?
Retrospective Studies
1
2011
2167
0.130
Why?
Prognosis
1
2008
1030
0.120
Why?
Cell Proliferation
1
2008
480
0.120
Why?
Phosphorylation
1
2008
754
0.120
Why?
Skin Neoplasms
1
2008
225
0.120
Why?
Administration, Oral
3
2007
302
0.120
Why?
Pneumonia
1
2006
188
0.110
Why?
Intestinal Polyps
1
2002
15
0.110
Why?
Drug Resistance, Neoplasm
2
2008
54
0.090
Why?
Melanoma
1
2001
133
0.080
Why?
Neoplasm Metastasis
2
2008
219
0.080
Why?
Carrier Proteins
1
2002
410
0.080
Why?
Mutagenesis
1
1999
130
0.080
Why?
DNA Repair
1
1999
168
0.070
Why?
Phenotype
2
2006
727
0.060
Why?
DNA-Binding Proteins
1
1999
661
0.060
Why?
Gene Expression Regulation, Neoplastic
2
2001
247
0.050
Why?
Demography
1
2011
95
0.050
Why?
Animals, Genetically Modified
1
2011
54
0.050
Why?
Genotype
1
2011
455
0.040
Why?
Chemokine CXCL12
1
2009
33
0.040
Why?
Cyclic S-Oxides
1
2009
1
0.040
Why?
Survival Analysis
1
2011
575
0.040
Why?
Thiadiazoles
1
2009
13
0.040
Why?
Oncogene Protein v-akt
1
2008
5
0.040
Why?
Cell Line, Transformed
1
2008
59
0.040
Why?
Neoplasm Staging
1
2010
326
0.040
Why?
Genomics
1
2008
43
0.040
Why?
Combined Modality Therapy
1
2010
459
0.040
Why?
Mice, Nude
1
2008
178
0.040
Why?
Neoplasm Invasiveness
1
2008
150
0.040
Why?
9,10-Dimethyl-1,2-benzanthracene
1
2008
36
0.040
Why?
Transcription, Genetic
1
2012
795
0.040
Why?
Survival Rate
1
2010
584
0.040
Why?
Epidermis
1
2008
82
0.040
Why?
Cat Diseases
1
2007
2
0.040
Why?
Young Adult
1
2011
1013
0.040
Why?
Urinalysis
1
2007
18
0.040
Why?
Stromal Cells
1
2007
69
0.030
Why?
Urinary Calculi
1
2007
32
0.030
Why?
Interleukin-6
1
2009
314
0.030
Why?
Cross-Over Studies
1
2007
117
0.030
Why?
Alleles
1
2006
200
0.030
Why?
Cell Movement
1
2008
352
0.030
Why?
Homozygote
1
2006
91
0.030
Why?
Cyclooxygenase 2
1
2007
211
0.030
Why?
Mice, Inbred C57BL
1
2011
1613
0.030
Why?
Stem Cells
1
2009
338
0.030
Why?
Macrophages, Alveolar
1
2006
115
0.030
Why?
Bronchoalveolar Lavage Fluid
1
2006
297
0.030
Why?
DNA Primers
1
2006
401
0.030
Why?
Time Factors
1
2011
3047
0.030
Why?
Cell Line
1
2009
1554
0.030
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2006
513
0.030
Why?
Magnetic Resonance Imaging
1
2009
928
0.030
Why?
Child
1
2011
3897
0.030
Why?
Adolescent
1
2011
4513
0.030
Why?
Culture Media, Conditioned
1
2002
60
0.030
Why?
Gene Targeting
1
2002
69
0.030
Why?
Cell Aging
1
2002
53
0.030
Why?
Base Sequence
1
2006
1681
0.020
Why?
cdc25 Phosphatases
1
2001
1
0.020
Why?
Cell Differentiation
1
2006
1021
0.020
Why?
Cyclin D1
1
2001
29
0.020
Why?
Proto-Oncogene Proteins c-myc
1
2001
46
0.020
Why?
S Phase
1
2001
44
0.020
Why?
G1 Phase
1
2001
51
0.020
Why?
Gene Silencing
1
2001
42
0.020
Why?
Cyclins
1
2001
52
0.020
Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2001
70
0.020
Why?
In Situ Hybridization
1
2001
293
0.020
Why?
Xeroderma Pigmentosum Group A Protein
1
1999
2
0.020
Why?
Fibroblasts
1
2002
514
0.020
Why?
Chimera
1
1999
34
0.020
Why?
Lac Operon
1
1999
53
0.020
Why?
Genes, Reporter
1
1999
206
0.020
Why?
Proteins
1
2001
435
0.020
Why?
Age Factors
1
1999
1060
0.020
Why?
RNA, Messenger
1
2002
1791
0.020
Why?
Brain
1
1999
1161
0.010
Why?

Visualizations


Hezel's Networks

Concepts
_
Co-Authors
_
Similar People
_
Same Department